These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

673 related items for PubMed ID: 23561273

  • 1. Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea.
    Jnawali HN, Hwang SC, Park YK, Kim H, Lee YS, Chung GT, Choe KH, Ryoo S.
    Diagn Microbiol Infect Dis; 2013 Jun; 76(2):187-96. PubMed ID: 23561273
    [Abstract] [Full Text] [Related]

  • 2. Detection of multidrug resistance in Mycobacterium tuberculosis.
    Sekiguchi J, Miyoshi-Akiyama T, Augustynowicz-Kopeć E, Zwolska Z, Kirikae F, Toyota E, Kobayashi I, Morita K, Kudo K, Kato S, Kuratsuji T, Mori T, Kirikae T.
    J Clin Microbiol; 2007 Jan; 45(1):179-92. PubMed ID: 17108078
    [Abstract] [Full Text] [Related]

  • 3. Determining Genotypic Drug Resistance by Ion Semiconductor Sequencing With the Ion AmpliSeq™ TB Panel in Multidrug-Resistant Mycobacterium tuberculosis Isolates.
    Park J, Shin SY, Kim K, Park K, Shin S, Ihm C.
    Ann Lab Med; 2018 Jul; 38(4):316-323. PubMed ID: 29611381
    [Abstract] [Full Text] [Related]

  • 4. Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables.
    Kambli P, Ajbani K, Nikam C, Sadani M, Shetty A, Udwadia Z, Georghiou SB, Rodwell TC, Catanzaro A, Rodrigues C.
    Int J Mycobacteriol; 2016 Mar; 5(1):1-6. PubMed ID: 26927983
    [Abstract] [Full Text] [Related]

  • 5. Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.
    Campbell PJ, Morlock GP, Sikes RD, Dalton TL, Metchock B, Starks AM, Hooks DP, Cowan LS, Plikaytis BB, Posey JE.
    Antimicrob Agents Chemother; 2011 May; 55(5):2032-41. PubMed ID: 21300839
    [Abstract] [Full Text] [Related]

  • 6. Sequence-based detection of first-line and second-line drugs resistance-associated mutations in Mycobacterium tuberculosis isolates in Isfahan, Iran.
    Safari M, Moghim S, Salehi M, Jafari R, Nasr Esfahani B.
    Infect Genet Evol; 2020 Nov; 85():104468. PubMed ID: 32711076
    [Abstract] [Full Text] [Related]

  • 7. Quadruple-first line drug resistance in Mycobacterium tuberculosis in Vietnam: What can we learn from genes?
    Nguyen HQ, Nguyen NV, Contamin L, Tran THT, Vu TT, Nguyen HV, Nguyen NLT, Nguyen ST, Dang AD, Bañuls AL, Nguyen VAT.
    Infect Genet Evol; 2017 Jun; 50():55-61. PubMed ID: 28214557
    [Abstract] [Full Text] [Related]

  • 8. [Analysis of genetic determinants of multidrug and extensively drug-resistant Mycobacterium tuberculosis using oligonucleotide microchip].
    Zimenkov DV, Kulagina EV, Antonova OV, Surzhikov SA, Bespiatykh IuA, Shitikov EA, Il'ina EN, Mikhaĭlovich VM, Zasedatelev AS, Griadunov DA.
    Mol Biol (Mosk); 2014 Jun; 48(2):251-64. PubMed ID: 25850294
    [Abstract] [Full Text] [Related]

  • 9. Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
    Bakuła Z, Napiórkowska A, Kamiński M, Augustynowicz-Kopeć E, Zwolska Z, Bielecki J, Jagielski T.
    J Microbiol Immunol Infect; 2016 Jun; 49(3):439-44. PubMed ID: 26117528
    [Abstract] [Full Text] [Related]

  • 10. Application of next-generation sequencing to detect variants of drug-resistant Mycobacterium tuberculosis: genotype-phenotype correlation.
    Ko DH, Lee EJ, Lee SK, Kim HS, Shin SY, Hyun J, Kim JS, Song W, Kim HS.
    Ann Clin Microbiol Antimicrob; 2019 Jan 03; 18(1):2. PubMed ID: 30606210
    [Abstract] [Full Text] [Related]

  • 11. Molecular characterization of drug-resistant and -susceptible Mycobacterium tuberculosis isolated from patients with tuberculosis in Korea.
    Yoon JH, Nam JS, Kim KJ, Choi Y, Lee H, Cho SN, Ro YT.
    Diagn Microbiol Infect Dis; 2012 Jan 03; 72(1):52-61. PubMed ID: 22078903
    [Abstract] [Full Text] [Related]

  • 12. Mechanisms of first-line antimicrobial resistance in multi-drug and extensively drug resistant strains of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa.
    Dookie N, Sturm AW, Moodley P.
    BMC Infect Dis; 2016 Oct 26; 16(1):609. PubMed ID: 27784282
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review.
    Georghiou SB, Magana M, Garfein RS, Catanzaro DG, Catanzaro A, Rodwell TC.
    PLoS One; 2012 Oct 26; 7(3):e33275. PubMed ID: 22479378
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countries.
    Ajbani K, Lin SY, Rodrigues C, Nguyen D, Arroyo F, Kaping J, Jackson L, Garfein RS, Catanzaro D, Eisenach K, Victor TC, Crudu V, Gler MT, Ismail N, Desmond E, Catanzaro A, Rodwell TC.
    Antimicrob Agents Chemother; 2015 Jan 26; 59(1):414-20. PubMed ID: 25367911
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of mutations conferring resistance among multi- and extensively drug-resistant Mycobacterium tuberculosis isolates in China.
    Chen Y, Zhao B, Liu HC, Sun Q, Zhao XQ, Liu ZG, Wan KL, Zhao LL.
    J Antibiot (Tokyo); 2016 Mar 26; 69(3):149-52. PubMed ID: 26486879
    [Abstract] [Full Text] [Related]

  • 16. [Conventional and molecular diagnosis in a group of patients with drug-resistant tuberculosis].
    Mindru R, Spînu V, Popa C, Botezatu E, Spătaru R.
    Pneumologia; 2014 Mar 26; 63(3):168-73. PubMed ID: 25420292
    [Abstract] [Full Text] [Related]

  • 17. Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.
    Oudghiri A, Karimi H, Chetioui F, Zakham F, Bourkadi JE, Elmessaoudi MD, Laglaoui A, Chaoui I, El Mzibri M.
    BMC Infect Dis; 2018 Feb 27; 18(1):98. PubMed ID: 29486710
    [Abstract] [Full Text] [Related]

  • 18. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM, Ahmad S, Mokaddas E, Eldeen HS, Joseph S.
    BMC Infect Dis; 2019 Jan 03; 19(1):3. PubMed ID: 30606116
    [Abstract] [Full Text] [Related]

  • 19. Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates.
    Mokrousov I, Bhanu NV, Suffys PN, Kadival GV, Yap SF, Cho SN, Jordaan AM, Narvskaya O, Singh UB, Gomes HM, Lee H, Kulkarni SP, Lim KC, Khan BK, van Soolingen D, Victor TC, Schouls LM.
    J Microbiol Methods; 2004 Jun 03; 57(3):323-35. PubMed ID: 15134881
    [Abstract] [Full Text] [Related]

  • 20. Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Hunan, China.
    Zhao LL, Chen Y, Chen ZN, Liu HC, Hu PL, Sun Q, Zhao XQ, Jiang Y, Li GL, Tan YH, Wan KL.
    Antimicrob Agents Chemother; 2014 Jun 03; 58(6):3475-80. PubMed ID: 24733464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.